small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search
  • Professionals (99)
  • Capabilities (51)
  • Experience (16)
  • Insights & News (1,281)
  • Other Results (34)

Professionals 99 results

Monica Lopez-Rodriguez
Monica Lopez-Rodriguez
Of Counsel
  • Miami
Email
+1 305-910-0501
vCard

Of Counsel

  • Miami
Cari Stinebower
Cari Stinebower
Partner
  • Washington, DC
Email
+1 202-282-5788
vCard

Partner

  • Washington, DC
Carl Fornaris
Carl Fornaris
Partner
  • Miami
Email
+1 305-910-0626
vCard

Partner

  • Miami
View All Professionals

Capabilities 51 results

Industry

Sports

Winston has one of the world’s premier sports law practices. Our work has included some of the most famous legal matters in sports history—including Alston v. NCAA, the case that culminated in a 9–0 Supreme Court victory for the college players against the NCAA; the US$2.15B Los Angeles Dodgers acquisition; McNeil v. the NFL, the landmark antitrust jury trial that led to the establishment of free agency in the NFL; the multi-billion-dollar construction and permanent financings for SoFi Stadium; and Morgan v. USSF, the case that led to a historic equal pay settlement for the players on the Women’s National Team. Our work is transforming this global, multibillion-dollar industry....Read more

Industry

Financial Crimes Compliance

Winston’s financial crimes compliance lawyers have been providing regulatory compliance counseling and enforcement services related to the Bank Secrecy Act (BSA), the Anti-Money Laundering Act of 2020 (AML), and countering the financing of terrorism (CFT) policy for decades. We also have experience with international AML matters, including in the EU and with respect to Financial Actions Task Force (FATF) recommendations....Read more

Industry

Medical Devices

The medical device industry is currently undergoing monumental change—from supply chain challenges to disruptive technologies and economic fluctuations. To pave the way for a more accessible and innovative health care landscape—including advances in wearables, implants, diagnostics, mobility, drug delivery—the evolving and expansive medical device industry faces wide-ranging legal needs. Clients in this sector can tap the remarkable depth and breadth of our sector-focused and skilled attorneys in the U.S. and abroad. Our Health Care & Life Sciences Industry Group engages clients at all points in the product development life cycle to provide sound advice and practical solutions regardless of the client’s size or the complexity of their need. We help clients navigate today’s complex regulatory landscape, defend products and reputations in the face of high-profile product liability and mass tort claims, protect innovative intellectual property (IP), and leverage cross-border experience to advise on commercial transactions....Read more

Experience 16 results

Experience

|

April 30, 2025

Federal Circuit Backs PayPal

In December 2022, Winston convinced Judge Albright of the W.D. Tex. to reverse his tentative construction and invalidate four patents based on means-plus-function indefiniteness at claim construction in the district court. Winston also persuaded Judge Albright to deny Fintiv’s motion for reconsideration the next month. Fintiv appealed to the Federal Circuit, which affirmed the district court in a precedential opinion in April 2025. Winston overcame a significant amount of sleight of hand from Fintiv, which continually shifted the purported structure of the “payment handler” term through claim construction, its motion for reconsideration, and appellate briefs, muddying the record. Ultimately the opinion clearly distinguished the factual record from that in Dyfan v. Target, curbing patentees abilities to argue that all code or applications are a “class of structures” and not indefinite under 112(f). The Federal Circuit affirmed four of the five patents Winston invalidated for PayPal, effectively foreclosing Fintiv’s ability to revive these patents for assertion. Winston also invalidated the fifth patent at the PTAB; Fintiv’s appeal of that Final Written Decision is pending....Read more

Experience

|

March 18, 2025

Winston Blunts Earnout Payment

Following a bench trial in Fall 2024, a New York trial court ruled in March 2025 that Cresco Labs, Inc. was not required to pay a US$45M earnout under a merger agreement. The court found that Cresco did not receive “commercially reasonable access” to New York’s adult-use cannabis market, which was supposed to be subject only to a non-competitive application or approval process. Adopting Cresco’s arguments, the court determined that only the Office of Cannabis Management and Cannabis Control Board could decide when and how applicants access the adult-use market. The court agreed that regulators required Cresco to pay a significant one-time fee, prioritized other applicants, and had broad discretion over approvals. This win supports claims that New York’s adult-use program lacks details and clear entry paths, frustrating industry leaders’ efforts to develop a robust adult-use market....Read more

Experience

|

September 27, 2024

Winston Represents KeHE Distributors, LLC in a $250.0 Million Senior Secured Notes Tack-On Offering

Winston represented KeHE Distributors, LLC in connection with a Rule 144A/Reg. S tack-on offering of $250,000,000 aggregate principal amount of 9.000% senior secured notes due 2029 issued by KeHE Distributors, LLC, NextWave Distribution, Inc. and KeHE Finance Corp. Proceeds from the offering were used to partially pay down existing ABL borrowings. KeHE Distributors, LLC is a leading pure-play natural and organic, specialty and fresh products food distributor in North America....Read more
View All Experience

Insights & News 1,281 results

Capital Markets & Securities Law Watch

|

September 25, 2025

|

5 Min Read

SEC Issues Policy Statement on Mandatory Arbitration Provisions and Acceleration of Registration Statement Effectiveness

On September 17, 2025, the Securities and Exchange Commission (SEC or the Commission) released a policy statement (the Policy Statement) addressing its approach to mandatory arbitration provisions in the governing documents of companies intending to go public (each, an Issuer).

Capital Markets & Securities Law Watch

|

September 16, 2025

|

7 Min Read

The FCA’s New Prospectus Rules: A Bold Reset for UK Capital Markets

On 15 July 2025, the Financial Conduct Authority (FCA) released Policy Statement PS25/9, confirming the final rules under the Public Offers and Admission to Trading Regulations 2024 (POATRs). These reforms overhaul the UK’s prospectus regime, replacing the retained EU Prospectus Regulation and taking effect from 19 January 2026. The new framework aims to simplify capital raising, reduce costs for issuers and enhance the UK’s competitiveness as a listing venue. 

The FCA’s reforms are part of a broader government strategy to ensure regulation is targeted, proportionate and growth-oriented. They follow extensive consultation, including CP24/12 and CP25/2, and reflect recommendations from Lord Hill’s UK Listing Review and the Secondary Capital Raising Review.

Client Alert

|

September 12, 2025

|

6 Min Read

Debanking Developments: OCC Bulletins Clarify Expectations, but Key Questions Remain

In this alert, Winston’s Financial Services Industry Group examines recent developments in debanking, focusing on two new OCC bulletins that clarify regulatory expectations. While these bulletins provide new insight into how the OCC is addressing debanking under the current administration, they also leave several important questions unanswered.

The OCC’s first bulletin addresses how politicized or unlawful debanking will factor into licensing applications and Community Reinvestment Act evaluations, emphasizing the importance of fair access and treatment. The second bulletin reminds banks of their obligations under the Right to Financial Privacy Act, particularly in light of recent congressional scrutiny, and underscores the need to protect customer financial records unless disclosure is legally required.

What does this mean for you? 

View All Insights & News

Other Results 34 results

Site Content

The Corporate Transparency Act
Task Force

Site Content

What Are AML Rules?

Anti-Money Laundering (AML) refers to policies and practices that prevent, detect, and report financial crimes. The principal U.S. federal law on money laundering is the Bank Secrecy Act (BSA), also known as the Currency and Foreign Transactions Reporting Act of 1970. The BSA generally mandates financial institutions to assist in governmental investigations by keeping records of cash purchases or negotiable instruments, filing reports of cash transactions exceeding a set daily aggregate amount, and reporting suspicious activity that may hint at money laundering, tax evasion, or other criminal activities....Read more

Site Content

What Is Tax Evasion?

Tax evasion is the failure to pay or the deliberate underpayment of federal income taxes. The U.S. income tax system is based on voluntary compliance, and it is the taxpayer’s responsibility to report all income and to pay all taxes due. Tax evasion is a known violation of a legal duty, and may result in monetary penalties, imprisonment, or both....Read more
Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2025. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising